Skip to Primary Navigation

White House pulls nominee to lead FDA ahead of key Senate vote

The nomination of Heidi Overton was rescinded amid concerns she lacked support among members of the Senate HELP Committee.

Article label: Quick Read
Premium article

The Trump administration has rescinded the nomination of Dr Heidi Overton to lead the US Food and Drug Administration on the eve of a key Senate vote amid concerns she lacked support among lawmakers.

To pass the Senate Committee on Health, Education, Labor and Pensions vote, Overton, a physician and

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience